Sitemap

January 30, 2008 Articles

Filter by Available Specialty
  1. Allergan reports 32% increase in fourth-quarter sales; oral glaucoma drug fails second phase 3 trial
  2. Ankle fractures in the elderly associated with low complication rate, regardless of treatment type
  3. Lux Biosciences granted FDA fast track designation for corneal transplant rejection drug
  4. PEDF may regulate corneal vascularization, prevent retinal neovascularization, study suggests
  5. Timolol may reduce post-phaco IOP increases in patients with glaucoma, exfoliation syndrome